We found a matchYour institution may have access to this item. Find your institution then sign in to continue.TitleSerum CA19-9 response as a surrogate for clinical outcome in patients receiving fixed-dose rate gemcitabine for advanced pancreatic cancer.AuthorsKo AH; Hwang J; Venook AP; Abbruzzese JL; Bergsland EK; Tempero MAPublicationBritish journal of cancer, 2005, Vol 93, Issue 2, p195ISSN0007-0920Publication typearticleDOI10.1038/sj.bjc.6602687